Vericel Corporation - Common Stock (VCEL)

Vericel Corporation is a biotechnology company that focuses on developing and commercializing innovative, cell-based products for a variety of medical needs

Specializing in regenerative medicine, Vericel primarily addresses the treatment of diseases and conditions affecting the skin and cartilage. Their flagship products are designed to enhance healing and improve patient outcomes, particularly in areas such as sports medicine and burn care. Through its commitment to research and development, Vericel aims to transform the treatment landscape for patients with complex medical needs.